Vaughan Nelson Investment Management L.P. Acquires Shares of 461,265 Revvity Inc. $RVTY

Vaughan Nelson Investment Management L.P. acquired a new position in Revvity Inc. (NYSE:RVTY) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 461,265 shares of the company’s stock, valued at approximately $40,411,000. Vaughan Nelson Investment Management L.P. owned 0.41% of Revvity as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Corient Private Wealth LLC increased its position in Revvity by 985.0% during the fourth quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock worth $12,245,000 after purchasing an additional 114,903 shares during the last quarter. SHP Wealth Management purchased a new stake in Revvity during the 4th quarter worth about $100,000. Pacer Advisors Inc. increased its holdings in Revvity by 4.7% during the 4th quarter. Pacer Advisors Inc. now owns 11,152 shares of the company’s stock worth $1,079,000 after purchasing an additional 504 shares during the period. Virtu Financial LLC acquired a new stake in Revvity in the 4th quarter valued at about $384,000. Finally, Alberta Investment Management Corp acquired a new stake in Revvity in the 4th quarter valued at about $1,442,000. 86.65% of the stock is owned by institutional investors and hedge funds.

Revvity Price Performance

Revvity stock opened at $100.47 on Monday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. The business has a 50 day simple moving average of $96.02 and a 200-day simple moving average of $97.58. Revvity Inc. has a 12 month low of $81.22 and a 12 month high of $118.30. The stock has a market capitalization of $11.21 billion, a PE ratio of 48.07, a price-to-earnings-growth ratio of 2.19 and a beta of 1.11.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The firm had revenue of $711.12 million for the quarter, compared to analyst estimates of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. Revvity’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the firm posted $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Equities analysts predict that Revvity Inc. will post 5.25 earnings per share for the current year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be paid a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s payout ratio is 13.40%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on RVTY. TD Cowen boosted their price objective on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Robert W. Baird set a $117.00 target price on shares of Revvity in a report on Wednesday, May 6th. JPMorgan Chase & Co. reduced their price objective on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating on the stock in a report on Wednesday, May 6th. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. Finally, Wolfe Research began coverage on shares of Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $107.73.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.